Urgently Completes Strategic Divestiture of The Floow in Support of Core Business Focus
September 20, 2024 08:00 ET
|
Urgent.ly Inc.
VIENNA, Va., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Urgent.ly, Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today...
Global Engine Group Holding Limited Announces Pricing of $8 Million Initial Public Offering
September 20, 2024 08:00 ET
|
Global Engine Group Holding Limited
Hong Kong, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Global Engine Group Holding Limited (the “Company” or “GLE”), a Hong Kong-headquartered integrated solutions provider in information communication...
Dr. Carlo Papa Appointed to Board of Directors of Odysight.ai
September 20, 2024 08:00 ET
|
Odysight.ai Inc.
OMER, Israel, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a pioneer in AI driven Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), is pleased to announce the...
Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”
September 20, 2024 08:00 ET
|
SINTX Technologies, Inc.
Salt Lake City, Utah, Sept. 20, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) a leader in advanced ceramics, and Prodways, a global specialist in 3D...
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ™
September 20, 2024 08:00 ET
|
Samsung Bioepis
OPUVIZ™, a biosimilar referencing Eylea1 (aflibercept), is Samsung Bioepis and Biogen’s second ophthalmology biosimilar to be recommended for marketing authorization by the European Medicines Agency ...
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm
September 20, 2024 08:00 ET
|
Kaskela Law
PHILADELPHIA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) on behalf of the company’s long-term...
Forge Battery Selected for $100M Award Negotiation with U.S. Department of Energy to Expand Production Capacity of North Carolina Lithium-Ion Battery Gigafactory
September 20, 2024 07:54 ET
|
Forge Nano
Forge Battery selected for award negotiation for Bipartisan Infrastructure Law funding for commercial-scale domestic production of lithium-ion battery cells for specialized marketsCompany to increase...
Vehicle Electrification Global Strategic Business Report 2024: Market to Reach $155.9 Billion by 2030 at a CAGR of 7.5%
September 20, 2024 07:48 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Vehicle Electrification - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Vehicle...
Communiqué de presse : Le CHMP recommande l’approbation du Dupixent dans l’UE pour le traitement de l’œsophagite à éosinophiles de l’enfant à partir de 12 mois
September 20, 2024 07:45 ET
|
Sanofi - Aventis Groupe
Le CHMP recommande l’approbation du Dupixent dans l’UE pour le traitement de l’œsophagite à éosinophiles de l’enfant à partir de 12 mois Recommandation fondée sur une étude de phase III ayant...
Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
September 20, 2024 07:45 ET
|
Sanofi - Aventis Groupe
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly greater...